Nitrous oxide

Description

Nitrous oxide, with the chemical name N2O, is a non-flammable gas classified as an oxidizer (5.1). It is recognized by the United States Pharmacopeia (USP) and has a CAS number of 10024-97-2.

Uses and Indications

Nitrous Oxide is indicated for use in medical settings where its administration is deemed appropriate by a licensed practitioner. This drug should only be administered by or under the supervision of a healthcare professional who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the drug's indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrous Oxide administration, which may render its use contraindicated in certain situations. There are no specific teratogenic or nonteratogenic effects documented for this drug.

Dosage and Administration

Administration of Nitrous Oxide is to be conducted exclusively by or under the supervision of a licensed practitioner who possesses experience in its use and administration, as it may pose hazards or contraindications.

The route of administration is via respiratory inhalation. The active ingredient is Nitrous Oxide, with a concentration of 99 liters in 100 liters. It is imperative that practitioners adhere to established safety protocols and guidelines when administering this agent to ensure patient safety and efficacy.

Contraindications

Administration of Nitrous Oxide is contraindicated in the following situations:

• Use is restricted to licensed practitioners experienced in its administration, who are knowledgeable about its indications, effects, dosages, methods, and potential hazards.

• Handling of Nitrous Oxide should not occur until all safety precautions have been thoroughly read and understood.

• Inhalation of the gas is contraindicated; avoid breathing in the gas.

• Contact with eyes, skin, or clothing must be avoided to prevent adverse reactions.

• The product should only be used and stored outdoors or in well-ventilated areas to mitigate risks associated with gas accumulation.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses expertise in its administration. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazardous Properties Nitrous Oxide is classified as an oxidizer and may cause or intensify fire. It is contained under pressure, which presents a risk of explosion if subjected to heat. Additionally, exposure to this gas may lead to drowsiness or dizziness, and it has the potential to displace oxygen, resulting in rapid suffocation. Frostbite may occur upon contact with the gas.

General Precautions Prior to handling Nitrous Oxide, all safety precautions must be thoroughly read and understood. It is essential to store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Users should avoid inhaling the gas and prevent contact with eyes, skin, or clothing. Nitrous Oxide should only be used and stored outdoors or in well-ventilated areas.

In the event of a fire, efforts should be made to stop the leak if it is safe to do so. A backflow preventive device must be utilized in the piping, and only equipment made from compatible materials and rated for cylinder pressure should be employed. Equipment must also be cleaned for oxygen service. Valves should be opened slowly and closed after each use or when empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). Users are advised to read and follow the Safety Data Sheet (SDS) prior to use.

Emergency Instructions In case of feeling unwell, it is crucial to seek immediate medical assistance by contacting a poison center or a physician. If Nitrous Oxide comes into contact with the skin, affected areas should be thawed with lukewarm water without rubbing. Immediate medical advice and attention should be sought in such instances.

Side Effects

Patients receiving Nitrous Oxide may experience a range of adverse reactions, which can vary in seriousness and frequency.

Serious adverse reactions include the potential for drowsiness or dizziness, which may impair the ability to perform tasks requiring alertness. Additionally, Nitrous Oxide is classified as an oxidizer and may cause or intensify fire, posing a significant risk in certain environments. There is also a risk of rapid suffocation due to oxygen displacement, which necessitates careful monitoring during administration. Frostbite is another serious concern, particularly if the gas comes into contact with the skin.

In clinical settings, the administration of Nitrous Oxide should be conducted only by or under the supervision of a licensed practitioner experienced in its use. This practitioner must be knowledgeable about the indications, effects, dosages, methods, and frequency of administration, as well as the associated hazards, contraindications, and side effects.

In the event of inhalation, it is crucial to remove the individual to fresh air and ensure they are comfortable for breathing. If the patient feels unwell, immediate medical assistance should be sought by contacting a poison center or physician. For skin exposure, it is advised to thaw any frosted areas with lukewarm water without rubbing the affected area, and to seek immediate medical advice or attention.

These precautions and responses are essential to mitigate the risks associated with Nitrous Oxide administration and to ensure patient safety.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide may pose hazards or be contraindicated in pediatric patients. It is essential that this agent is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions specific to pediatric patients.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Administration of Nitrous Oxide during pregnancy may pose potential risks and is considered hazardous or contraindicated. There is no specific information available regarding the safety of Nitrous Oxide use in pregnant patients, including any associated fetal outcomes or necessary dosage modifications. Due to the lack of data, it is recommended that Nitrous Oxide be used only by or under the supervision of a licensed practitioner who is experienced in its administration. Healthcare professionals should exercise caution and consider alternative options when treating pregnant patients.

Lactation

There is no specific information regarding the use of Nitrous Oxide in nursing mothers or its effects on lactation. Consequently, healthcare professionals should exercise caution when considering the administration of this agent to lactating mothers. The potential impact on breastfed infants has not been established, and further research may be necessary to clarify any associated risks.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the insert for Nitrous Oxide. Healthcare professionals should exercise caution and consider the lack of data when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be tailored to the individual patient and may involve supportive care, including monitoring vital signs and providing symptomatic treatment as necessary. In cases of significant overdose, consultation with a poison control center or a medical toxicologist is recommended to determine the most appropriate course of action.

It is crucial for healthcare professionals to educate patients about the importance of adhering to prescribed dosages and to provide guidance on what to do in the event of a suspected overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No specific postmarketing experience details are available. As such, there are no reported adverse events or case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards and is contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide, including its ability to cause or intensify fire, as it is classified as an oxidizer. They should be cautioned that the gas is under pressure and may explode if heated. Additionally, patients should be informed that Nitrous Oxide may cause drowsiness or dizziness, and it can displace oxygen, leading to rapid suffocation. Frostbite is another risk associated with exposure to this gas.

It is crucial for patients to understand the importance of reading and comprehending all safety precautions before handling Nitrous Oxide. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should avoid breathing the gas and should take care to prevent contact with eyes, skin, or clothing.

Healthcare providers should emphasize the necessity of using and storing Nitrous Oxide only outdoors or in well-ventilated areas. In the event of a fire, patients should be advised to stop the leak if it is safe to do so. The use of a backflow preventive device in the piping is recommended, along with the use of equipment made from compatible materials and rated for cylinder pressure. Equipment must also be cleaned for oxygen service, and patients should be instructed to open the valve slowly and close it after each use and when empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F).

Patients should be encouraged to read and follow the Safety Data Sheet (SDS) prior to use. In case of an emergency, healthcare providers should inform patients of the first aid measures: if inhaled, they should be removed to fresh air and kept comfortable for breathing, and a poison center or physician should be contacted if they feel unwell. If Nitrous Oxide comes into contact with the skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in configurations that ensure safe handling and storage. It is essential to keep the product away from clothing and other combustible materials to prevent fire hazards. Valves and fittings must be maintained free from grease and oil to ensure safe operation.

For optimal use, the product should only be utilized and stored outdoors or in a well-ventilated area. It is crucial to protect the product from sunlight when the ambient temperature exceeds 52°C (125°F) to prevent degradation or safety risks.

When operating the valve, it should be opened slowly, and it is important to close the valve after each use and when the product is empty. A backflow preventive device must be employed in the piping to ensure safety and compliance.

The product should only be used with equipment that is constructed from compatible materials and rated for cylinder pressure. Additionally, it is imperative to use equipment that has been cleaned for oxygen service to maintain safety standards.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Boggs Gases div. Boggs Fire Equipment. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)